The FDA has approved Moderna’s mRNA-based seasonal flu vaccine for adults 50 and older, marking the first such approval in the U.S.
The FDA has approved Moderna’s mRNA-based seasonal flu vaccine for adults 50 and older, marking the first such approval in the U.S.
‘Caught between a rock and a hard place’: Prof. Ram Sasisekharan.
The American Bazaar is a publication of American Bazaar, Inc., based in Germantown, MD.

